Congress Probes Hospitals for Alleged Favoritism in Organ Transplant Allocations

Congress Probes Hospitals for Alleged Favoritism in Organ Transplant Allocations

House lawmakers have initiated a congressional investigation into two prominent hospital systems. These investigations arise amid serious allegations suggesting that the hospitals permitted wealthy foreign patients to bypass United States organ transplant waiting lists. Currently, over 100,000 Americans are on those lists, with thousands succumbing each year while waiting for lifesaving organs.

Representatives Jason Smith from Missouri and David Schweikert from Arizona spearhead the House Ways and Means Committee’s oversight effort. On Tuesday, they dispatched formal letters to the University of Chicago Medical Center and Montefiore Medical Center in New York. These letters demanded records by February 10 and threatened subpoenas if the hospitals failed to comply.

Serious Allegations from the New York Times

The allegations, first reported by the New York Times, assert that these tax-exempt hospitals provided transplants to foreign nationals seeking medical services in the United States, effectively jumping ahead of American patients on waiting lists. Smith and Schweikert emphasized that such actions might contribute to loss of life among American patients waiting for transplants.

Smith articulated that the allegations strike at the heart of what tax-exempt hospitals should stand for. Therefore, these claims could instigate a comprehensive review of whether those tax benefits should continue.

U.S. Hospitals Under Scrutiny

Smith remarked, “If U.S. hospitals that enjoy generous taxpayer-funded benefits have prioritized foreign nationals for organ transplants over saving American lives, their tax-exempt status should be revoked.” He added, “America First means prioritizing American lives, not profits. The Ways and Means Committee will leave no stone unturned and is ready to employ every tool at our disposal, including subpoenas, to uncover the truth.”

In their correspondence with the University of Chicago Medical Center President Thomas Jackiewicz, lawmakers expressed particular concern over the hospital’s transplant statistics. Astonishingly, foreign patients accounted for approximately 11% of the hospital’s heart and lung transplants. Between 2020 and 2024, 61 international patients received organs there, more than any other hospital in the United States.

Preferential Treatment Allegations

Lawmakers cited instances where foreign patients allegedly received organs within mere days, while American patients languished on the waiting list for significantly longer periods.

One notable case involved a wealthy Japanese woman who reportedly underwent a heart transplant just three days after being added to the waiting list. Authorities found that an exception had raised her priority, and she was a self-pay international recipient. Following the surgery, a charity established by her husband donated money to a nonprofit associated with the transplant surgeon’s family. Such developments raised eyebrows regarding a potential quid pro quo arrangement.

The letter sent to the hospital underscored the alarm among transplant experts, suggesting that wealth, connections, and charitable contributions following transplantation may have intersected with access to scarce organs.

Tax-Exempt Status Under Fire

Lawmakers further questioned whether the hospital fulfilled its responsibilities as a tax-exempt institution. They pointed out allegations that the hospital entered into contracts with foreign governments for transplant services.

The lawmakers stated, “Contracting with a foreign government to provide these crucial services to international patients rather than American citizens raises serious questions regarding the community benefit necessary to maintain tax-exempt status.”

A similar letter addressed to Philip O. Ozuah, President and CEO of Montefiore Medical Center, detailed comparable concerns. Reports indicated that overseas patients constituted around 20% of lung transplant recipients at Montefiore, bringing in tens of millions of dollars in revenue for the hospital.

Allegations of Preferential Advertising

The letter alleged that Montefiore promoted its transplant services abroad by showcasing minimal wait times and offering concierge care. Whistleblowers further claimed that international patients favored preferential treatment, with allegations of altering or omitting medical records to expedite access to organs.

Testimonies from a former transplant financial coordinator reported that American patients were often sidelined. The coordinator recounted, “We had patients who we’d been working with, who had been waiting their turn, and then someone from Kuwait would come and jump the line.”

The Impact on American Patients

Smith and Schweikert highlighted the gravity of the situation. Currently, more than 100,000 Americans are awaiting organ transplants, with about 5,600 dying each year while on the waiting list.

“Montefiore’s decision to prioritize foreign nationals for this vital service — and their preferential treatment over American citizens — in exchange for substantial payments far exceeding market rates is profoundly inappropriate,” the letter stated.

Ongoing Congressional Investigations

These demands come during a broader congressional investigation into the U.S. organ transplant system. Schweikert noted that the investigation has already yielded results, notably the Trump administration’s decision to decertify a Miami organ procurement organization. He mentioned that testimonies at a December hearing uncovered shocking accounts of organ donation failures. Such revelations highlighted the pressing need for increased transparency within the transplant system.

As the investigation unfolds, the implications for American patients and the ethical responsibilities of U.S. hospitals will likely remain at the forefront of the national dialogue.